Seely Lynn

Lyell Immunopharma, Inc. ยท President and CEO

Seely Lynn is listed in public filings as director, officer: President and CEO. This Seely Lynn insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Lyell Immunopharma, Inc. (LYEL), and Blueprint Medicines Corporation (BPMC). Investors use Seely Lynn's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Lyell Immunopharma, Inc.LYEL$1.7M74.3k sharesSellFeb 11, 2026$174.4K7.5k shares$23.39--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Lyell Immunopharma, Inc.LYEL$3.7M155k sharesGrant / ExerciseFeb 10, 2026$3.7M155k shares$23.71--
Lyell Immunopharma, Inc.LYEL$1.9M81.7k sharesSellFeb 10, 2026$10.1K438 shares$23.12--
Lyell Immunopharma, Inc.LYEL--82.2k sharesGrant / ExerciseFeb 9, 2026Disclosure amount unavailable20k shares----
Lyell Immunopharma, Inc.LYEL$1.1M67.2k sharesSellNov 10, 2025$6.6K412 shares$16.11--
Lyell Immunopharma, Inc.LYEL$3.0M175k sharesGrant / ExerciseOct 27, 2025$3.0M175k shares$17.23--
Lyell Immunopharma, Inc.LYEL$712k67.6k sharesSellAug 21, 2025$76.5K7.3k shares$10.54--
Lyell Immunopharma, Inc.LYEL--74.8k sharesGrant / ExerciseAug 20, 2025Disclosure amount unavailable40k shares----
Lyell Immunopharma, Inc.LYEL$360k34.8k sharesSellAug 12, 2025$4.2K406 shares$10.34--
Lyell Immunopharma, Inc.LYEL$371k35.2k sharesSellAug 11, 2025$4.1K391 shares$10.53--
Blueprint Medicines CorporationBPMC$07.5k sharesOtherJul 17, 2025$523.4K7.5k shares$69.79--
Blueprint Medicines CorporationBPMC$010.9k sharesOtherJul 17, 2025$502.0K10.9k shares$46.02--
Blueprint Medicines CorporationBPMC$04.6k sharesOtherJul 17, 2025$485.1K4.6k shares$106.14--
Blueprint Medicines CorporationBPMC$04.9k sharesOtherJul 17, 2025$471.8K4.9k shares$96.77--
Blueprint Medicines CorporationBPMC$021.8k sharesOtherJul 17, 2025$416.3K21.8k shares$19.08--
Blueprint Medicines CorporationBPMC$04.5k sharesOtherJul 17, 2025$392.1K4.5k shares$87.13--
Blueprint Medicines CorporationBPMC$04.5k sharesOtherJul 17, 2025$343.1K4.5k shares$76.24--
Blueprint Medicines CorporationBPMC$05.3k sharesOtherJul 17, 2025$337.4K5.3k shares$63.66--
Blueprint Medicines CorporationBPMC$05.3k sharesOtherJul 17, 2025$268.4K5.3k shares$50.64--
Blueprint Medicines CorporationBPMC$010.9k sharesOtherJul 17, 2025$213.1K10.9k shares$19.53--
Blueprint Medicines CorporationBPMC--13.3k sharesOtherJul 17, 2025Disclosure amount unavailable13.3k shares----
Blueprint Medicines CorporationBPMC--13.3k sharesOtherJul 17, 2025Disclosure amount unavailable3.9k shares----
Blueprint Medicines CorporationBPMC$2.2M17.2k sharesGrant / ExerciseJun 18, 2025$499.9K3.9k shares$128.12--
Lyell Immunopharma, Inc.LYEL$432k712.5k sharesBuyMar 14, 2025$106.2K175k shares$0.6068--
Lyell Immunopharma, Inc.LYEL$747k1.4M sharesGrant / ExerciseFeb 10, 2025$747.2K1.4M shares$0.5535--
Lyell Immunopharma, Inc.LYEL--537.5k sharesGrant / ExerciseFeb 10, 2025Disclosure amount unavailable337.5k shares----
Lyell Immunopharma, Inc.LYEL$93k168.8k sharesGrant / ExerciseFeb 10, 2025$93.4K168.8k shares$0.5535--